Finance

Lists
Why is ANVS up 2,94%?
Dive Deeper
ANVS:NYSE
Annovis Bio Inc
1,05 US$
+2,94%
(+0,030) 1D
1,08 US$
+2,86% (+0,030)
After hours
Closed: 15 ოქტ, 16:00:07 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANVS...
Open
1,04 US$
High
1,08 US$
Low
1,01 US$
Mkt. cap
44,81 მლნ.
Avg. vol.
1,21 მლნ.
Volume
572,22 ათ.
52-wk high
5,50 US$
52-wk low
1,01 US$
EPS
-1,78 US$
Beta
1,23
Shares outstanding
42,68 მლნ.
No. of employees
8
Open
1,04 US$
High
1,08 US$
Low
1,01 US$
Mkt. cap
44,81 მლნ.
Avg. vol.
1,21 მლნ.
Volume
572,22 ათ.
52-wk high
5,50 US$
52-wk low
1,01 US$
EPS
-1,78 US$
Beta
1,23
Shares outstanding
42,68 მლნ.
No. of employees
8
News stories
From web sources and news partners
The Spokesman-Review
The Spokesman-Review
·
28 წუთის წინ
S&P 500 ends higher as traders shift from AI to healthcare
Yahoo Finance
Yahoo Finance
·
44 წუთის წინ
The S&P 500 Went More Than 50 Trading Days Without a 1% Drop. That Streak Just Ended. What's Next?
MarketBeat
MarketBeat
·
1 საათის წინ
StoneX Group (NASDAQ:SNEX) CEO Sells 45,000 Shares of Company Stock
Investor's Business Daily
Investor's Business Daily
·
1 საათის წინ
Anthropic Value Report Hits Tech Futures; Tesla Touts Roadster
About Annovis Bio Inc
CEOMaria-luisa Maccecchini
Employees8
Founded2008
HeadquartersMalvern, პენსილვანია, ამერიკის შეერთებული შტატები
Sector-
Websiteannovisbio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ANVS in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ANVS in the last 3 months.
Highest
Current 1,05 US$
17,00 US$ (+1 519,05%)
Average
10,67 US$ (+916,19%)
Lowest
7,00 US$ (+566,67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
7,00 US$
+566,7%
09/04/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
17,00 US$
+1 519%
08/18/2026
Jason McCarthy
Maxim Group
Buy
Maintained
8,00 US$
+661,9%
08/17/2026
Unknown Analyst
Roth MKM
Buy
Initiated
8,00 US$
+661,9%
07/07/2026
Last report
14 აგვ. 2026
Fiscal period
Q2 2026
-0,40 US$ / -0,46 US$
+13,04%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6,29 მლნ.
8,75 მლნ.
16,72 მლნ.
12,01 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,14 მლნ.
955,15 ათ.
1,19 მლნ.
2,37 მლნ.
Operating expense
7,43 მლნ.
9,71 მლნ.
17,91 მლნ.
14,38 მლნ.
Total operating expenses
7,43 მლნ.
9,71 მლნ.
17,91 მლნ.
14,38 მლნ.
Operating income
-7,43 მლნ.
-9,71 მლნ.
-17,91 მლნ.
-14,38 მლნ.
Other non operating income
20,00 ათ.
-296,00 ათ.
268,00 ათ.
-603,34 ათ.
EBT including unusual items
-7,26 მლნ.
-9,83 მლნ.
-17,61 მლნ.
-14,82 მლნ.
EBT excluding unusual items
-7,26 მლნ.
-9,83 მლნ.
-17,51 მლნ.
-14,82 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,26 მლნ.
-9,83 მლნ.
-17,61 მლნ.
-14,82 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,37
-0,39
-0,63
-0,40
Interest and investment income
152,32 ათ.
167,74 ათ.
137,80 ათ.
160,23 ათ.
Interest expense
-
-
-
-
Net interest expenses
152,32 ათ.
167,74 ათ.
137,80 ათ.
160,23 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები